A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells

Immunity

Volumn 34, Issue 3, 2011, Pages 327-339

  Wun, Kwok S ^a   Cameron, Garth ^b   Patel, Onisha ^a   Pang, Siew Siew ^a   Pellicci, Daniel G ^b   Sullivan, Lucy C ^b   Keshipeddy, Santosh ^c   Young, Mary H ^d   Uldrich, Adam P ^b   Thakur, Meena S ^c   Richardson, Stewart K ^c   Howell, Amy R ^c   Illarionov, Petr A ^e   Brooks, Andrew G ^b   Besra, Gurdyal S ^e   McCluskey, James ^b   Gapin, Laurent ^d   Porcelli, Steven A ^f   Godfrey, Dale I ^b   Rossjohn, Jamie ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; PHYTOSPHINGOSINE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR DOCKING; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1D; CARBOHYDRATE SEQUENCE; CELL LINE; CELL PROLIFERATION; EPITOPES; GLYCOLIPIDS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; RECEPTORS, NATURAL KILLER CELL;

EID: 79952770879     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.02.001     Document Type: Article

References (41)

1. Aleksic M., Dushek O., Zhang H., Shenderov E., Chen J.-L., Cerundolo V., Coombs D., van der Merwe P.A. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity 2010, 32:163-174.
2. Archbold J.K., Macdonald W.A., Gras S., Ely L.K., Miles J.J., Bell M.J., Brennan R.M., Beddoe T., Wilce M.C., Clements C.S., et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 2009, 206:209-219.
3. Bai L., Sagiv Y., Liu Y., Freigang S., Yu K.O., Teyton L., Porcelli S.A., Savage P.B., Bendelac A. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc. Natl. Acad. Sci. USA 2009, 106:10254-10259.
4. Baker B.M., Gagnon S.J., Biddison W.E., Wiley D.C. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling. Immunity 2000, 13:475-484.
5. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
6. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C., Pellicci D.G., Koh R., Besra G.S., Bharadwaj M., Godfrey D.I., McCluskey J., Rossjohn J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007, 448:44-49.
7. Brutkiewicz R.R. CD1d ligands: The good, the bad, and the ugly. J. Immunol. 2006, 177:769-775.
8. Cerundolo V., Silk J.D., Masri S.H., Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 2009, 9:28-38.
9. Degano M., Garcia K.C., Apostolopoulos V., Rudolph M.G., Teyton L., Wilson I.A. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 2000, 12:251-261.
10. Florence W.C., Xia C., Gordy L.E., Chen W., Zhang Y., Scott-Browne J., Kinjo Y., Yu K.O., Keshipeddy S., Pellicci D.G., et al. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J. 2009, 28:3579-3590.
11. Gadola S.D., Koch M., Marles-Wright J., Lissin N.M., Shepherd D., Matulis G., Harlos K., Villiger P.M., Stuart D.I., Jakobsen B.K., et al. Structure and binding kinetics of three different human CD1d-α-galactosylceramide-specific T cell receptors. J. Exp. Med. 2006, 203:699-710.
12. Gapin L. iNKT cell autoreactivity: What is 'self' and how is it recognized?. Nat. Rev. Immunol. 2010, 10:272-277.
13. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: What's in a name?. Nat. Rev. Immunol. 2004, 4:231-237.
14. Godfrey D.I., Rossjohn J., McCluskey J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 2008, 28:304-314.
15. Godfrey D.I., Pellicci D.G., Patel O., Kjer-Nielsen L., McCluskey J., Rossjohn J. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 2010, 22:61-67.
16. Govern C.C., Paczosa M.K., Chakraborty A.K., Huseby E.S. Fast on-rates allow short dwell time ligands to activate T cells. Proc. Natl. Acad. Sci. USA 2010, 107:8724-8729.
17. Huppa J.B., Axmann M., Mörtelmaier M.A., Lillemeier B.F., Newell E.W., Brameshuber M., Klein L.O., Schütz G.J., Davis M.M. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 2010, 463:963-967.
18. Im J.S., Arora P., Bricard G., Molano A., Venkataswamy M.M., Baine I., Jerud E.S., Goldberg M.F., Baena A., Yu K.O., et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009, 30:888-898.
19. Jervis P.J., Veerapen N., Bricard G., Cox L.R., Porcelli S.A., Besra G.S. Synthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramides. Bioorg. Med. Chem. Lett. 2010, 20:3475-3478.
20. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
21. Kjer-Nielsen L., Borg N.A., Pellicci D.G., Beddoe T., Kostenko L., Clements C.S., Williamson N.A., Smyth M.J., Besra G.S., Reid H.H., et al. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 2006, 203:661-673.
22. Li Y., Girardi E., Wang J., Yu E.D., Painter G.F., Kronenberg M., Zajonc D.M. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J. Exp. Med. 2010, 207:2383-2393.
23. Mallevaey T., Scott-Browne J.P., Matsuda J.L., Young M.H., Pellicci D.G., Patel O., Thakur M., Kjer-Nielsen L., Richardson S.K., Cerundolo V., et al. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 2009, 31:60-71.
24. Mallevaey T., Clarke A.J., Scott-Browne J., Young M.H., Roisman L.C., Pellicci D.G., Patel O., Vivian J.P., Matsuda J.L., McCluskey J., et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011, 34:315-326. this issue.
25. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.-R., Koezuka Y., Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000, 192:741-754.
26. Matulis G., Sanderson J.P., Lissin N.M., Asparuhova M.B., Bommineni G.R., Schümperli D., Schmidt R.R., Villiger P.M., Jakobsen B.K., Gadola S.D. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. PLoS Biol. 2010, 8:e1000402.
27. McCarthy C., Shepherd D., Fleire S., Stronge V.S., Koch M., Illarionov P.A., Bossi G., Salio M., Denkberg G., Reddington F., et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J. Exp. Med. 2007, 204:1131-1144.
28. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001, 413:531-534.
29. Pellicci D.G., Patel O., Kjer-Nielsen L., Pang S.S., Sullivan L.C., Kyparissoudis K., Brooks A.G., Reid H.H., Gras S., Lucet I.S., et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 2009, 31:47-59.
30. Raju R., Castillo B.F., Richardson S.K., Thakur M., Severins R., Kronenberg M., Howell A.R. Synthesis and evaluation of 3″- and 4″-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000. Bioorg. Med. Chem. Lett. 2009, 19:4122-4125.
31. Schiefner A., Fujio M., Wu D., Wong C.-H., Wilson I.A. Structural evaluation of potent NKT cell agonists: Implications for design of novel stimulatory ligands. J. Mol. Biol. 2009, 394:71-82.
32. Schmieg J., Yang G., Franck R.W., Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide. J. Exp. Med. 2003, 198:1631-1641.
33. Scott-Browne J.P., Matsuda J.L., Mallevaey T., White J., Borg N.A., McCluskey J., Rossjohn J., Kappler J., Marrack P., Gapin L. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 2007, 8:1105-1113.
34. Sloan-Lancaster J., Allen P.M. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 2003, 14:1-27.
35. Stanic A.K., Shashidharamurthy R., Bezbradica J.S., Matsuki N., Yoshimura Y., Miyake S., Choi E.Y., Schell T.D., Van Kaer L., Tevethia S.S., et al. Another view of T cell antigen recognition: Cooperative engagement of glycolipid antigens by Va14Ja18 natural TCR. J. Immunol. 2003, 171:4539-4551.
36. Sullivan B.A., Nagarajan N.A., Wingender G., Wang J., Scott I., Tsuji M., Franck R.W., Porcelli S.A., Zajonc D.M., Kronenberg M. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J. Immunol. 2010, 184:141-153.
37. Tynan F.E., Reid H.H., Kjer-Nielsen L., Miles J.J., Wilce M.C., Kostenko L., Borg N.A., Williamson N.A., Beddoe T., Purcell A.W., et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 2007, 8:268-276.
38. van der Merwe P.A., Davis S.J. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 2003, 21:659-684.
39. Venkataswamy M.M., Porcelli S.A. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin. Immunol. 2010, 22:68-78.
40. Wun K.S., Borg N.A., Kjer-Nielsen L., Beddoe T., Koh R., Richardson S.K., Thakur M., Howell A.R., Scott-Browne J.P., Gapin L., et al. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 2008, 205:939-949.
41. Yu K.O., Im J.S., Molano A., Dutronc Y., Illarionov P.A., Forestier C., Fujiwara N., Arias I., Miyake S., Yamamura T., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. USA 2005, 102:3383-3388.